Drugs / DTaP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00467519 | Apr 2007 → Nov 2009 | diphtheria, pertussis, tetanus | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTaP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00467519 ↗ |
| Modality | Vaccine | “DTaP vaccine” NCT00467519 ↗ |
| Route | Intramuscular | “0.5 mL, IM” NCT00467519 ↗ |